Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Extended proof-of-concept and drug interaction studies complete for IDX-899

Oct. 8, 2010

Preclinical and early clinical data reported on BC-3781

Oct. 8, 2010

Artemether sublingual spray is safe and efficacious in children with severe malaria

Oct. 7, 2010

SNPs in PIK3C2B gene correlate with risk of Parkinson's disease

Oct. 7, 2010

Neutrophil elastase inhibitor AZD-9668 shows promise in COPD

Oct. 7, 2010

Tuberculosis candidate PNU-100480 is well tolerated in healthy volunteers

Oct. 7, 2010

LMV-601 is potently active against HSV and HPV in preclinical studies

Oct. 7, 2010

Phase II rasagiline trial in parkinsonian multiple system atrophy / News in Context

Oct. 6, 2010

AS-2041835 and micafungin show synergistic antifungal activity in preclinical study

Oct. 6, 2010

Zabofloxacin shows cardiac safety in phase I trial in healthy subjects

Oct. 6, 2010

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...